Figures released by the Obesity Health Alliance this week predict an additional 670,000 new cancer diagnoses in the UK over the next 20 years if the current obesity trend continues.
Equivalent pain, functional and cosmetic outcomes reported by early-stage breast cancer patients receiving hypofractionated whole-breast irradiationm when compared with patients undergoing conventionally fractionated whole-breast irradiation.
New research has defined molecular subgroups associated with varying prognoses in early bladder cancer, which could potentially lead to optimization of disease therapy.
This Commentary article from Future Oncology discusses express approvals of immune checkpoint inhibitors, providing opinion on the need to address the value of these agents in each setting and develop clear guidelines for their appropriate use.
Oncogenic gene fusions of neurotrophic tyrosine kinase genes have been identified in solid tumors and studies have shown them to be associated with worse survival in all types of lung cancer – is there any potential in inhibitors of these genes in the disease?
This primary research article from Biomarkers in Medicine investigates the diagnostic potential of FGFR3/Cyclin D3 urinary protein levels in detecting bladder cancer recurrence.